The present invention provides compositions comprising a DNA-nanostructure and at least one targeting moiety, wherein the at least one targeting moiety is linked to the DNA-nanostructure and wherein the at least one targeting moiety is selected from the group consisting of antigens, aptamers, shRNAs and combinations thereof, and methods of use thereof.
